Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized open-label study of antibiotic prophylaxis for positive intraoperative cultures in hip arthroplasty
2008-008854-22Phase 4Active
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Mar 2009
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of piperacillin + tazobactam in surgical site infection (SSI) and infection prophylaxis (2 arms), sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Incidence of surgical wound infection. Started Mar 2009; status: active.
02
Drugs
piperacillin + tazobactam
03
Conditions
surgical site infection (SSI)infection prophylaxis
Beyond the preview
Go deeper on 2008-008854-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008854-22.